Game-changing technology delivers pre and post-performance data in seconds

MuscleSound, a Denver-based company with patented methodology and software that significantly improves athletes’ performance and reduces injury, today announced its partnership with the Dallas Mavericks National Basketball Team. MuscleSound provides Mavericks players the ability to measure muscle glycogen levels pre and post-performance in seconds using portable, high-frequency ultrasound technology.

Until recently, muscle glycogen content levels could only be measured through muscle biopsy or MRI. The MuscleSound cloud-based software generates easy-to-read reports with real-time data based upon ultrasound images for each player.

Unlike other technologies that provide data after performance for reactive injury management, MuscleSound is the only company that delivers pre-performance data and insight enabling immediate, personalized nutritional and performance-based recommendations for concentrated muscle recovery and injury prevention. MuscleSound post-performance scans can indicate muscle fatigue, overtraining and possible muscle damage.

“Until now we haven’t been able to measure glycogen levels in ‘real time’ after and before practices and games,” said Casey Smith, Head Athletic Trainer of the Dallas Mavericks. “MuscleSound enables us to develop a customized plan for each player with muscle-specific data allowing for personalized nutritional and training recommendations, as well as indications of overtraining and possible muscle damage.”

“We are honored to work with the Mavericks to showcase MuscleSound cutting edge technology,” said Stephen Kurtz, Chief Executive Officer of MuscleSound. “We are confident their athletes will see positive change in performance and a reduction in injuries.”

In addition to the Dallas Mavericks, MuscleSound is also working with Major League Baseball – specifically the Colorado Rockies – and will soon be announcing partnerships with professional and collegiate teams, as well as other elite athletes.

View on Reuters